Equillium collaborates with Vivtex for oral formulation of autoimmune therapy
The partnership will see AI-enabled screening used to address bioavailability issues with Equillium’s cytokine-targeting peptide.
The partnership will see AI-enabled screening used to address bioavailability issues with Equillium’s cytokine-targeting peptide.
What's Your Reaction?
